These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How 'killer' T cells could boost COVID immunity in face of new variants. Ledford H Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217 [No Abstract] [Full Text] [Related]
6. Plasma Neutralization of the SARS-CoV-2 Omicron Variant. Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645 [No Abstract] [Full Text] [Related]
7. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. Wang Y; Ma Y; Xu Y; Liu J; Li X; Chen Y; Chen Y; Xie J; Xiao L; Xiang Z; Wu F; Huang J Emerg Microbes Infect; 2022 Dec; 11(1):424-427. PubMed ID: 35001836 [No Abstract] [Full Text] [Related]
8. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine. Zhou X; Wang H; Ji Q; Du M; Liang Y; Li H; Li F; Shang H; Zhu X; Wang W; Jiang L; Stepanov AV; Ma T; Gong N; Jia X; Gabibov AG; Lou Z; Lu Y; Guo Y; Zhang H; Yang X Protein Cell; 2021 Oct; 12(10):818-823. PubMed ID: 33909239 [No Abstract] [Full Text] [Related]
9. Coronavirus variants are spreading in India - what scientists know so far. Vaidyanathan G Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409 [No Abstract] [Full Text] [Related]
10. The long road. Cohen J Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838 [No Abstract] [Full Text] [Related]
11. What the Omicron wave is revealing about human immunity. Willyard C Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764 [No Abstract] [Full Text] [Related]
12. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines. Wang Y EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128 [No Abstract] [Full Text] [Related]
13. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287 [TBL] [Abstract][Full Text] [Related]
14. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants. Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181 [TBL] [Abstract][Full Text] [Related]
15. Scientists see a 'really, really tough winter' with Omicron. Kupferschmidt K Science; 2021 Dec; 374(6574):1421-1422. PubMed ID: 34914506 [No Abstract] [Full Text] [Related]
16. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. Martin P; Clarke C EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401 [No Abstract] [Full Text] [Related]
17. Can immune responses predict which vaccines work best? Cohen J Science; 2021 Jul; 373(6551):142-143. PubMed ID: 34244387 [No Abstract] [Full Text] [Related]
18. Why does the Omicron sub-variant spread faster than the original? Callaway E Nature; 2022 Feb; 602(7898):556-557. PubMed ID: 35177843 [No Abstract] [Full Text] [Related]